Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung

Toshiyuki Kozuki, Akiko Hisamoto, Masahiro Tabata, Nagio Takigawa, Katsuyuki Kiura, Yoshihiko Segawa, Masao Nakata, Koichi Mandai, Kenji Eguchi, Hiroshi Ueoka, Mitsune Tanimoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Recently, a mutation of the epidermal growth factor receptor (EGFR) gene has been reported to be implicated in the development of pulmonary adenocarcinoma. However, the involvement of the mutation in atypical adenomatous hyperplasia (AAH) and multiple adenocarcinomas still remains unclear. We herein examined the EGFR mutations in 9 AAH and 31 adenocarcinoma lesions obtained from 30 Japanese patients. Nine patients had synchronous or metachronous multiple adenocarcinomas and/or AAH. Mutations in exons 18-21 of EGFR gene were analysed using polymerase chain reaction and direct sequence methods. EGFR mutations were detected in 4 (44%) of 9 AAH and in 7 (23%) of 31 adenocarcinomas. A gefitinib-resistant point mutation (T790M) in exon 20 without gefitinib treatment was detected in 1 AAH and 1 adenocarcinoma. The patient with T790M mutated AAH, which also had an exon 19 mutation of D761Y, had synchronous adenocarcinoma, which had only an exon 19 mutation of D761Y. The other exon 19 mutations were all in-frame deletions. In the two patients with synchronous AAH and adenocarcinoma, AAH had mutations at exon 19 although adenocarcinoma did not have any mutations. In the patient with synchronous 2 adenocarcinomas, each had different mutations (exons 19 and 21). In two patients with double adenocarcinomas, 1 adenocarcinoma harbored exon 21 mutations, while the other demonstrated no mutations. Although EGFR mutations appeared to be partially associated with the early steps of adenocarcinoma development, such mutations may possibly occur randomly even in multiple lesions in a single patient.

Original languageEnglish
Pages (from-to)30-35
Number of pages6
JournalLung Cancer
Volume58
Issue number1
DOIs
Publication statusPublished - Oct 2007

Fingerprint

erbB-1 Genes
Adenocarcinoma
Mutation
Hyperplasia
Exons
Epidermal Growth Factor Receptor
Adenocarcinoma of lung

Keywords

  • Adenocarcinoma
  • Atypical adenomatous hyperplasia
  • D761Y
  • Epidermal growth factor receptor (EGFR) mutation
  • Lung neoplasms
  • Multiple lesions

ASJC Scopus subject areas

  • Oncology

Cite this

Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. / Kozuki, Toshiyuki; Hisamoto, Akiko; Tabata, Masahiro; Takigawa, Nagio; Kiura, Katsuyuki; Segawa, Yoshihiko; Nakata, Masao; Mandai, Koichi; Eguchi, Kenji; Ueoka, Hiroshi; Tanimoto, Mitsune.

In: Lung Cancer, Vol. 58, No. 1, 10.2007, p. 30-35.

Research output: Contribution to journalArticle

Kozuki, T, Hisamoto, A, Tabata, M, Takigawa, N, Kiura, K, Segawa, Y, Nakata, M, Mandai, K, Eguchi, K, Ueoka, H & Tanimoto, M 2007, 'Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung', Lung Cancer, vol. 58, no. 1, pp. 30-35. https://doi.org/10.1016/j.lungcan.2007.04.011
Kozuki, Toshiyuki ; Hisamoto, Akiko ; Tabata, Masahiro ; Takigawa, Nagio ; Kiura, Katsuyuki ; Segawa, Yoshihiko ; Nakata, Masao ; Mandai, Koichi ; Eguchi, Kenji ; Ueoka, Hiroshi ; Tanimoto, Mitsune. / Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. In: Lung Cancer. 2007 ; Vol. 58, No. 1. pp. 30-35.
@article{edb9bca79fc14a1cbedb2730db00c4ee,
title = "Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung",
abstract = "Recently, a mutation of the epidermal growth factor receptor (EGFR) gene has been reported to be implicated in the development of pulmonary adenocarcinoma. However, the involvement of the mutation in atypical adenomatous hyperplasia (AAH) and multiple adenocarcinomas still remains unclear. We herein examined the EGFR mutations in 9 AAH and 31 adenocarcinoma lesions obtained from 30 Japanese patients. Nine patients had synchronous or metachronous multiple adenocarcinomas and/or AAH. Mutations in exons 18-21 of EGFR gene were analysed using polymerase chain reaction and direct sequence methods. EGFR mutations were detected in 4 (44{\%}) of 9 AAH and in 7 (23{\%}) of 31 adenocarcinomas. A gefitinib-resistant point mutation (T790M) in exon 20 without gefitinib treatment was detected in 1 AAH and 1 adenocarcinoma. The patient with T790M mutated AAH, which also had an exon 19 mutation of D761Y, had synchronous adenocarcinoma, which had only an exon 19 mutation of D761Y. The other exon 19 mutations were all in-frame deletions. In the two patients with synchronous AAH and adenocarcinoma, AAH had mutations at exon 19 although adenocarcinoma did not have any mutations. In the patient with synchronous 2 adenocarcinomas, each had different mutations (exons 19 and 21). In two patients with double adenocarcinomas, 1 adenocarcinoma harbored exon 21 mutations, while the other demonstrated no mutations. Although EGFR mutations appeared to be partially associated with the early steps of adenocarcinoma development, such mutations may possibly occur randomly even in multiple lesions in a single patient.",
keywords = "Adenocarcinoma, Atypical adenomatous hyperplasia, D761Y, Epidermal growth factor receptor (EGFR) mutation, Lung neoplasms, Multiple lesions",
author = "Toshiyuki Kozuki and Akiko Hisamoto and Masahiro Tabata and Nagio Takigawa and Katsuyuki Kiura and Yoshihiko Segawa and Masao Nakata and Koichi Mandai and Kenji Eguchi and Hiroshi Ueoka and Mitsune Tanimoto",
year = "2007",
month = "10",
doi = "10.1016/j.lungcan.2007.04.011",
language = "English",
volume = "58",
pages = "30--35",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung

AU - Kozuki, Toshiyuki

AU - Hisamoto, Akiko

AU - Tabata, Masahiro

AU - Takigawa, Nagio

AU - Kiura, Katsuyuki

AU - Segawa, Yoshihiko

AU - Nakata, Masao

AU - Mandai, Koichi

AU - Eguchi, Kenji

AU - Ueoka, Hiroshi

AU - Tanimoto, Mitsune

PY - 2007/10

Y1 - 2007/10

N2 - Recently, a mutation of the epidermal growth factor receptor (EGFR) gene has been reported to be implicated in the development of pulmonary adenocarcinoma. However, the involvement of the mutation in atypical adenomatous hyperplasia (AAH) and multiple adenocarcinomas still remains unclear. We herein examined the EGFR mutations in 9 AAH and 31 adenocarcinoma lesions obtained from 30 Japanese patients. Nine patients had synchronous or metachronous multiple adenocarcinomas and/or AAH. Mutations in exons 18-21 of EGFR gene were analysed using polymerase chain reaction and direct sequence methods. EGFR mutations were detected in 4 (44%) of 9 AAH and in 7 (23%) of 31 adenocarcinomas. A gefitinib-resistant point mutation (T790M) in exon 20 without gefitinib treatment was detected in 1 AAH and 1 adenocarcinoma. The patient with T790M mutated AAH, which also had an exon 19 mutation of D761Y, had synchronous adenocarcinoma, which had only an exon 19 mutation of D761Y. The other exon 19 mutations were all in-frame deletions. In the two patients with synchronous AAH and adenocarcinoma, AAH had mutations at exon 19 although adenocarcinoma did not have any mutations. In the patient with synchronous 2 adenocarcinomas, each had different mutations (exons 19 and 21). In two patients with double adenocarcinomas, 1 adenocarcinoma harbored exon 21 mutations, while the other demonstrated no mutations. Although EGFR mutations appeared to be partially associated with the early steps of adenocarcinoma development, such mutations may possibly occur randomly even in multiple lesions in a single patient.

AB - Recently, a mutation of the epidermal growth factor receptor (EGFR) gene has been reported to be implicated in the development of pulmonary adenocarcinoma. However, the involvement of the mutation in atypical adenomatous hyperplasia (AAH) and multiple adenocarcinomas still remains unclear. We herein examined the EGFR mutations in 9 AAH and 31 adenocarcinoma lesions obtained from 30 Japanese patients. Nine patients had synchronous or metachronous multiple adenocarcinomas and/or AAH. Mutations in exons 18-21 of EGFR gene were analysed using polymerase chain reaction and direct sequence methods. EGFR mutations were detected in 4 (44%) of 9 AAH and in 7 (23%) of 31 adenocarcinomas. A gefitinib-resistant point mutation (T790M) in exon 20 without gefitinib treatment was detected in 1 AAH and 1 adenocarcinoma. The patient with T790M mutated AAH, which also had an exon 19 mutation of D761Y, had synchronous adenocarcinoma, which had only an exon 19 mutation of D761Y. The other exon 19 mutations were all in-frame deletions. In the two patients with synchronous AAH and adenocarcinoma, AAH had mutations at exon 19 although adenocarcinoma did not have any mutations. In the patient with synchronous 2 adenocarcinomas, each had different mutations (exons 19 and 21). In two patients with double adenocarcinomas, 1 adenocarcinoma harbored exon 21 mutations, while the other demonstrated no mutations. Although EGFR mutations appeared to be partially associated with the early steps of adenocarcinoma development, such mutations may possibly occur randomly even in multiple lesions in a single patient.

KW - Adenocarcinoma

KW - Atypical adenomatous hyperplasia

KW - D761Y

KW - Epidermal growth factor receptor (EGFR) mutation

KW - Lung neoplasms

KW - Multiple lesions

UR - http://www.scopus.com/inward/record.url?scp=34548509720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548509720&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2007.04.011

DO - 10.1016/j.lungcan.2007.04.011

M3 - Article

C2 - 17561305

AN - SCOPUS:34548509720

VL - 58

SP - 30

EP - 35

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -